News
Nirvana, a healthcare technology startup, uses artificial intelligence to better predict insurance coverage. When Kelvin Chan ...
TIX100 is a small molecule inhibitor of TXNIP, a protein involved in cellular stress response and metabolism. This protein ...
The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Plans expect cell and gene therapies to pose a moderate or major financial challenge in the next two to three years, ...
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Cost is a barrier to care for chronic and rare diseases, so financial assistance is way to lower that barrier and help people ...
At this year’s Asembia Specialty Pharmacy Summit in Las Vegas, Managed Healthcare Executive spoke with John Beardsley, senior ...
Adult and pediatric generalized myasthenia gravis patients have a new, longer acting option for treatment called Imaavy.
A decision is expected in the fourth quarter of 2025.
The new research center at the University of Michigan and Oregon Health & Science University intends to develop a clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results